Active Substance & Generic Molecule Directory

Meloxicam in Malaysia: Registered Brands, Dosages & Price Comparison

Directory of all approved pharmaceutical brands containing Meloxicam registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).

14
Registered Brands
Availability in Malaysia:9 Prescription (MAL-A)
Showing 14 of 14 registered brands
MAL Reg NoBrand Formulation NameStrength / DosageClassificationRegistration HolderAction
MAL08111899AZAROXICAM TABLETS 15MG15.00 mg 0Prescription (MAL-A)UNIMED SDN. BHD.Compare →
MAL10033143ACZAvegesic Tablet 15mg15 mg 0Prescription (MAL-A)APEX PHARMACY MARKETING SDN. BHD.Compare →
MAL18056181AZDYNA MELOXICAM TABLET 7.5MG7.5mg 0Prescription (MAL-A)DYNAPHARM (M) SDN. BHD.Compare →
MAL08080401AZMELARTIN TABLET 15 mg15.00 mgPrescription (MAL-A)RANBAXY (MALAYSIA) SDN. BHD.Compare →
MAL13035051AZMelocam Tablet 15mg15.0mg 180.0mgPrescription (MAL-A)Y.S.P. INDUSTRIES (M) SDN. BHD.Compare →
MAL20040203AZMELONEX-15MG TABLETS15MGPrescription (MAL-A)JETPHARMA SDN. BHD.Compare →
MAL24086157HAMELOX 1.5MG/ML SUSPENSION1.5 mg 1 mlVeterinary (MAL-V)RANGE PHARMA SDN. BHD.Compare →
MAL20032426AZMELOX 15MG TABLETS15MGPrescription (MAL-A)KOMEDIC SDN BHDCompare →
MAL07011004AZMeloxim 15mg Tablet15 mg 0Prescription (MAL-A)STERILINE SDN. BHD.Compare →
MAL11060027ACZMobic Tablet 7.5 mg7.5 mg 0Prescription (MAL-A)BOEHRINGER INGELHEIM (MALAYSIA) SDN. BHD.Compare →
MAL22016031HARRheumocam 0.5mg/ml Oral Suspension for Cats0.5 mg/mLVeterinary (MAL-V)Rhone Ma Malaysia Sdn BhdCompare →
MAL11070051HARRheumocam 1.5mg/ml oral suspension for dogs0.15 % (W/V)Veterinary (MAL-V)Rhone Ma Malaysia Sdn BhdCompare →
MAL18046022HARRheumocam 2.5mg Chewable Tablets for Dogs2.5 mgVeterinary (MAL-V)Rhone Ma Malaysia Sdn BhdCompare →
MAL24036045HACRHEUMOCAM 5MG/ML INJECTION5 mg/mLVeterinary (MAL-V)PET ARCADE SDN BHDCompare →

Generic Bioequivalence & Drug Substitution in Malaysia

Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.